Clinical Trial Update: Pilot Study of Edaravone to Treat Acute Myocardial Infarction [Phase 4]

View source ↗

Summary

This update reports results from a Phase 4 pilot trial of edaravone to treat acute myocardial infarction, including reperfusion injury.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• Reperfusion Injury

Drugs mentioned

• Edaravone (Edaravone)

Snippet

Sponsor: Kumamoto University | Conditions: Myocardial Infarction, Reperfusion Injury | Phase 4 | Status: COMPLETED | Results posted: 2014-09-15